Viracta TherapeuticsVIRX
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 32 institutions reported holding Viracta Therapeutics Inc. (VIRX) in their 13F filings, down 6 from Q3 2024. 5 opened new positions and 11 sold out. The largest holders were Citadel Advisors ($262K), Vanguard Group Inc. ($47K) and Aisling Capital Management LP ($46K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Viracta Therapeutics Inc.
- CUSIP
- 92765F108
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $35K |
| Exits | 11 | $386K |
All 13F filers, Q3 2024 → Q4 2024: 465,185 shares bought and 2,429,231 shares sold, net −1,964,046 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 32 holders
| Citadel Advisors | 0.00% | Add +7.0% | 1,626,258 | $262K |
| Vanguard Group Inc. | 0.00% | Reduce -69.7% | 289,174 | $47K |
| Aisling Capital Management LP | 0.02% | No change | 288,571 | $46K |
| Renaissance Technologies | 0.00% | Add +16.7% | 286,395 | $46K |
| BlackRock, Inc. | 0.00% | No change | 234,846 | $38K |
| Geode Capital Management, LLC | 0.00% | Reduce -10.3% | 224,250 | $36K |
| Virtu Financial LLC | 0.00% | New | 128,231 | $21K |
| UBS Group AG | 0.00% | Add +97981.1% | 93,177 | $15K |
| HRT Financial LP | 0.00% | Reduce -40.5% | 82,673 | $13K |
| State Street Corp. | 0.00% | No change | 65,867 | $11K |
| Jane Street Group, LLC | 0.00% | New | 55,422 | $9K |
| United Capital Financial Advisors, LLC | 0.00% | No change | 42,995 | $7K |
| Northern Trust Corp. | 0.00% | No change | 38,104 | $6K |
| Morgan Stanley | 0.00% | Add +17.8% | 36,135 | $6K |
| Inspirion Wealth Advisors, LLC | 0.00% | No change | 25,000 | $5K |
| Two Sigma Securities, LLC | 0.00% | New | 16,491 | $3K |
| WealthTrust Axiom LLC | 0.00% | No change | 16,396 | $3K |
| XTX Topco Ltd | 0.00% | Add +45.6% | 14,809 | $2K |
| Focus Partners Wealth | 0.00% | No change | 14,000 | $2K |
| Trust Co. of Toledo NA | 0.00% | No change | 12,317 | $2K |
| Baader Bank Aktiengesellschaft | 0.00% | New | 10,826 | $2K |
| RP Management, LLC | 0.00% | No change | 3,700 | $851 |
| MAI Capital Management | 0.00% | New | 4,018 | $647 |
| IAG Wealth Partners, LLC | 0.00% | No change | 3,000 | $483 |
| Bank of America Corp. | 0.00% | Reduce -92.5% | 1,124 | $180 |
| Oarsman Capital, Inc. | 0.00% | No change | 1,000 | $161 |
| JPMorgan Chase & Co. | 0.00% | No change | 721 | $116 |
| Indiana Trust & Investment Management Co | 0.00% | No change | 200 | $32 |
| SBI Securities Co., Ltd. | 0.00% | — | 180 | $29 |
| Wells Fargo & Company | 0.00% | No change | 171 | $28 |
| Parallel Advisors, LLC | 0.00% | No change | 8 | $1 |
| Addison Advisors LLC | 0.00% | No change | 4 | $1 |
"% of holder's portfolio" is VIRX's weight in each manager's 13F, not the share of Viracta Therapeutics Inc. the manager owns.